The specific alteration of histone methylation profiles by DZNep during early zebrafish development

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 11, 2014, Pages 1307-1315

  Østrup, Olga ^a,b   Reiner, Andrew H ^b   Aleström, Peter ^c   Collas, Philippe ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

DZNep; Embryo development; Histone methylation; Zebrafish

Indexed keywords

3 DEAZANEPLANOCIN A; 3-DEAZANEPLANOCIN; ADENOSINE; HISTONE; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; TRANSCRIPTOME;

ARTICLE; BLASTULA; CELL POPULATION; CHROMATIN; EMBRYO; EMBRYO DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; HISTONE METHYLATION; NONHUMAN; PHENOTYPE; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; ZEBRA FISH; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL EMBRYO; DRUG EFFECTS; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHYLATION;

DANIO RERIO;

ADENOSINE; ANIMALS; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; METHYLATION; PROMOTER REGIONS, GENETIC; TRANSCRIPTOME; ZEBRAFISH;

EID: 84908439306     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.09.013     Document Type: Article

References (50)

1. Abdel-Wahab O., Levine R.L. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood 2013, 121:3563-3572.
2. Vecchio L., Seke Etet P.F., Kipanyula M.J., Krampera M., Nwabo Kamdje A.H. Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: what can be learned from hematologic malignancies?. Biochim. Biophys. Acta 1836, 2013:90-104.
3. Rebucci M., Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem. Pharmacol. 2013, 85:1219-1226.
4. Fiskus W., Rao R., Balusu R., Ganguly S., Tao J., Sotomayor E., et al. Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells. Clin. Cancer Res. 2012, 18:6227-6238.
5. Tan J., Yang X., Zhuang L., Jiang X., Chen W., Lee P.L., et al. Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 2007, 21:1050-1063.
6. Gannon O.M., Merida de L.L., Endo-Munoz L., Hazar-Rethinam M., Saunders N.A. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Clin. Cancer Res. 2013, 19:428-441.
7. Sato T., Kaneda A., Tsuji S., Isagawa T., Yamamoto S., Fujita T., et al. PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer. Sci. Rep. 2013, 3:1911-.
8. Bachmann I.M., Halvorsen O.J., Collett K., Stefansson I.M., Straume O., Haukaas S.A., et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol. 2006, 24:268-273.
9. Wagener N., Macher-Goeppinger S., Pritsch M., Husing J., Hoppe-Seyler K., Schirmacher P., et al. Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma. BMC Cancer 2010, 10:524-.
10. Margueron R., Reinberg D. The polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
11. Glazer R.I., Knode M.C., Tseng C.K., Haines D.R., Marquez V.E. 3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells. Biochem. Pharmacol. 1986, 35:4523-4527.
12. Miranda T.B., Cortez C.C., Yoo C.B., Liang G., Abe M., Kelly T.K., et al. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther. 2009, 8:1579-1588.
13. Kikuchi J., Takashina T., Kinoshita I., Kikuchi E., Shimizu Y., Sakakibara-Konishi J., et al. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer 2012, 78:138-143.
14. Cheng L.L., Itahana Y., Lei Z.D., Chia N.Y., Wu Y., Yu Y., et al. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin. Cancer Res. 2012, 18:4201-4212.
15. Lindeman L.C., Andersen I.S., Reiner A.H., Li N., Aanes H., Ostrup O., et al. Prepatterning of developmental gene expression by modified histones before zygotic genome activation. Dev. Cell 2011, 21:993-1004.
16. Ostrup O., Andersen I.S., Collas P. Chromatin-linked determinants of zygotic genome activation. Cell. Mol. Life Sci. 2013, 70:1425-1437.
17. Zhou J., Bi C., Cheong L.L., Mahara S., Liu S.C., Tay K.G., et al. The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML. Blood 2011, 118:2830-2839.
18. Panzica-Kelly J.M., Zhang C.X., Danberry T.L., Flood A., DeLan J.W., Brannen K.C., et al. Morphological score assignment guidelines for the dechorionated zebrafish teratogenicity assay. Birth Defects Res. B Dev. Reprod. Toxicol. 2010, 89:382-395.
19. Shechter D., Dormann H.L., Allis C.D., Hake S.B. Extraction, purification and analysis of histones. Nat. Protoc. 2007, 2:1445-1457.
20. Lindeman L.C., Vogt-Kielland L.T., Alestrom P., Collas P. Fish'n ChIPs: chromatin immunoprecipitation in the zebrafish embryo. Methods Mol. Biol. 2009, 567:75-86.
21. Song J.S., Johnson W.E., Zhu X., Zhang X., Li W., Manrai A.K., et al. Model-based analysis of two-color arrays (MA2C). Genome Biol. 2007, 8:R178-.
22. Huang dW, Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
23. Liu T.A., Bhuiyan S., Snow R., Yasuda S., Yasuda T., Yang Y.S., et al. Identification and characterization of two novel cytosolic sulfotransferases, SULT1 ST7 and SULT1 ST8, from zebrafish. Aquat. Toxicol. 2008, 89:94-102.
24. Mohammed Y.I., Kurogi K., Shaban A.A., Xu Z., Liu M.Y., Williams F.E., et al. Identification and characterization of zebrafish SULT1 ST9, SULT3 ST4, and SULT3 ST5. Aquat. Toxicol. 2012, 112-113:11-18.
25. Walsh J.E., Young M.R. Interrelationship between protein phosphatase 1 and TGF-{beta} in regulating motility and cytoskeletal architecture of endothelial cells. Anticancer Res. 2010, 30:4861-4866.
26. Rojas A.M., Fuentes G., Rausell A., Valencia A. The Ras protein superfamily: evolutionary tree and role of conserved amino acids. J. Cell Biol. 2012, 196:189-201.
27. Eklund E. The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis. Crit. Rev. Oncog. 2011, 16:65-76.
28. Aanes H., Winata C.L., Lin C.H., Chen J.P., Srinivasan K.G., Lee S.G., et al. Zebrafish mRNA sequencing deciphers novelties in transcriptome dynamics during maternal to zygotic transition. Genome Res. 2011, 21:1328-1338.
29. Mansour A.A., Gafni O., Weinberger L., Zviran A., Ayyash M., Rais Y., et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature 2012, 488:409-413.
30. Dahl J.A., Reiner A.H., Collas P. Fast genomic muChIP-chip from 1,000 cells. Genome Biol. 2009, 10:R13-.
31. Andersen I.S., Ostrup O., Lindeman L.C., Aanes H., Reiner A.H., Mathavan S., et al. Epigenetic complexity during the zebrafish mid-blastula transition. Biochem. Biophys. Res. Commun. 2012, 417:1139-1144.
32. Au S.L., Wong C.C., Lee J.M., Wong C.M., Ng I.O. EZH2-mediated H3K27me3 is involved in epigenetic repression of deleted in liver cancer 1 in human cancers. PLoS One 2013, 8:e68226-.
33. Fadloun A., Eid A., Torres-Padilla M.E. Mechanisms and dynamics of heterochromatin formation during mammalian development: closed paths and open questions. Curr. Top. Dev. Biol. 2013, 104:1-45.
34. Islam A.B., Richter W.F., Lopez-Bigas N., Benevolenskaya E.V. Selective targeting of histone methylation. Cell Cycle 2011, 10:413-424.
35. Hunter R.G., Murakami G., Dewell S., Seligsohn M., Baker M.E., Datson N.A., et al. Acute stress and hippocampal histone H3 lysine 9 trimethylation, a retrotransposon silencing response. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:17657-17662.
36. Xie Z., Bi C., Cheong L.L., Liu S.C., Huang G., Zhou J., et al. Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells. PLoS One 2011, 6:e21583-.
37. Mills A.A. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat. Rev. Cancer 2010, 10:669-682.
38. Thatcher K.N., LaSalle J.M. Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2. Epigenetics 2006, 1:24-31.
39. Rai K., Jafri I.F., Chidester S., James S.R., Karpf A.R., Cairns B.R., et al. Dnmt3 and G9a cooperate for tissue-specific development in zebrafish. J. Biol. Chem. 2010, 285:4110-4121.
40. Nicetto D., Hahn M., Jung J., Schneider T.D., Straub T., David R., et al. Suv4-20h histone methyltransferases promote neuroectodermal differentiation by silencing the pluripotency-associated Oct-25 gene. PLoS Genet. 2013, 9:e1003188-.
41. Avan A., Crea F., Paolicchi E., Funel N., Galvani E., Marquez V.E., et al. Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells. Mol. Cancer Ther. 2012, 11:1735-1746.
42. Chiba T., Suzuki E., Negishi M., Saraya A., Miyagi S., Konuma T., et al. 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells. Int. J. Cancer 2012, 130:2557-2567.
43. Momparler R.L., Idaghdour Y., Marquez V.E., Momparler L.F. Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation. Leuk. Res. 2012, 36:1049-1054.
44. Harris R.M., Waring R.H. Sulfotransferase inhibition: potential impact of diet and environmental chemicals on steroid metabolism and drug detoxification. Curr. Drug Metab. 2008, 9:269-275.
45. Liu J., Mercher T., Scholl C., Brumme K., Gilliland D.G., Zhu N. A functional role for the histone demethylase UTX in normal and malignant hematopoietic cells. Exp. Hematol. 2012, 40:487-498.
46. Tarayrah L., Herz H.M., Shilatifard A., Chen X. Histone demethylase dUTX antagonizes JAK-STAT signaling to maintain proper gene expression and architecture of the Drosophila testis niche. Development 2013, 140:1014-1023.
47. Chaturvedi C.P., Somasundaram B., Singh K., Carpenedo R.L., Stanford W.L., Dilworth F.J., et al. Maintenance of gene silencing by the coordinate action of the H3K9 methyltransferase G9a/KMT1C and the H3K4 demethylase Jarid1a/KDM5A. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:18845-18850.
48. Xu M., Soloveychik M., Ranger M., Schertzberg M., Shah Z., Raisner R., et al. Timing of transcriptional quiescence during gametogenesis is controlled by global histone H3K4 demethylation. Dev. Cell 2012, 23:1059-1071.
49. Lee J.H., Skalnik D.G. Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A Histone H3-Lys4 methyltransferase complex to transcription start sites of transcribed human genes. Mol. Cell. Biol. 2008, 28:609-618.
50. Di S.L., Ji J.Y., Moon N.S., Herr A., Dyson N. Mutation of Drosophila Lsd1 disrupts H3-K4 methylation, resulting in tissue-specific defects during development. Curr. Biol. 2007, 17:808-812.